May & Baker Nigeria Plc has said it plans to grow its drug manufacturing and distribution business by 75 per cent in 2017 from a turnover of over N6 billion in 2016.
This was disclosed by Mr. Chukuka Chukutem, Executive Director, Pharma Sales & Marketing at an interactive session with distributors of the company.
Chukutem said the company plans to achieve this through regular product availability, introduction of new products, increased brand support and promotion as well as a well mapped out distributor support and incentive system that would make them grow their businesses.
The Managing Director of May & Baker, Mr. Nnamdi Okafor said despite the economic recessionthe company had over18 per cent turnover growth in 2016 when compared to 2015, averaging 11 per cent increase.
During the forum, the company launched a new product, Easadol Suspension, a flavoured pain relief for children.